Provided by Tiger Trade Technology Pte. Ltd.

Kiora Pharmaceuticals

2.75
+0.09003.38%
Post-market: 2.74-0.0100-0.36%16:10 EDT
Volume:10.55K
Turnover:28.45K
Market Cap:12.19M
PE:-1.14
High:2.75
Open:2.65
Low:2.65
Close:2.66
52wk High:2.95
52wk Low:1.76
Shares:4.43M
Float Shares:3.85M
Volume Ratio:0.61
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4100
EPS(LYR):-2.6400
ROE:-56.36%
ROA:-21.92%
PB:0.72
PE(LYR):-1.04

Loading ...

Kiora Pharmaceuticals: Global KIO-301 Partnerships and Advancing ABACUS-2 Study Support Buy Rating with Unchanged $12 Price Target

TIPRANKS
·
Aug 21

Kiora Pharma Licenses South Korea Rights for KIO-301 to Chong Kun Dang in $1 Million Deal

Reuters
·
Aug 19

Kiora Pharmaceuticals - Ckd to Pay Kiora $1 Mln Up-Front Under Agreement - SEC Filing

THOMSON REUTERS
·
Aug 19

Kiora Pharmaceuticals - Ckd Granted Exclusive License for Kio-301 in South Korea for Ophthalmology - SEC Filing

THOMSON REUTERS
·
Aug 19

Kiora Pharmaceuticals - Eligible for Double Digit Royalties on Net Sales of Kio-301 in South Korea - SEC Filing

THOMSON REUTERS
·
Aug 19

Analysts Have Conflicting Sentiments on These Healthcare Companies: Joint (JYNT) and Kiora Pharmaceuticals (KPRX)

TIPRANKS
·
Aug 09

Kiora Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Kiora Q2 FY26 Net Loss Narrows to $2.1 Million

Reuters
·
Aug 07

Kiora Pharmaceuticals, Inc. Expected to Post a Loss of 62 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Analysts Are Bullish on Top Healthcare Stocks: Ascentage Pharma Group International (HK:6855), Kiora Pharmaceuticals (KPRX)

TIPRANKS
·
Jun 20

Kiora says KIO-300 suppresses seizure activity in preclinical epilepsy model

Reuters
·
Jun 18

Kiora Pharmaceuticals shareholders approve 1.5 million-share increase to 2024 equity incentive plan

Reuters
·
Jun 11

Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders

TIPRANKS
·
May 19

Kiora Pharmaceuticals Inc - Files Prospectus for Resale of up to 11.8 Mln Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
May 19

Analysts Are Bullish on Top Healthcare Stocks: Kiora Pharmaceuticals (KPRX), Myomo (MYO)

TIPRANKS
·
May 10

Kiora Pharmaceuticals Q1 EPS $(0.58) Beats $(0.71) Estimate

Benzinga Earnings
·
May 08

Kiora Pharmaceuticals Inc - Q1 Loss per Share $0.58 - SEC Filing

THOMSON REUTERS
·
May 08

Kiora Q1 FY26 net loss widens to $2.42 million; operating loss widens to $2.51 million

Reuters
·
May 08

Kiora Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
May 05

Kiora Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01